Cirrus: Recipharm completes acquisition of Kemwell AB and Cirrus Pharmaceuticals Inc. and resolve on share issues
On 18 April 2016, Recipharm announced that it had entered into two separate agreements to acquire pharmaceutical contract development and manufacturing operations (CDMO) from Kemwell. The first acquisition comprises operations in the US and Sweden, and the
Read full article »
CEO
Cirruspharm is a Private company. Cirruspharm generates $247.5K in revenue per employee Cirruspharm has 1 followers on Owler.